Brokerages Anticipate Entegris Inc (ENTG) to Announce $0.49 Earnings Per Share

Share on StockTwits

Equities research analysts expect Entegris Inc (NASDAQ:ENTG) to report $0.49 earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have provided estimates for Entegris’ earnings. The lowest EPS estimate is $0.49 and the highest is $0.50. Entegris reported earnings of $0.40 per share during the same quarter last year, which would suggest a positive year over year growth rate of 22.5%. The business is expected to report its next earnings results before the market opens on Thursday, October 25th.

On average, analysts expect that Entegris will report full-year earnings of $1.95 per share for the current financial year, with EPS estimates ranging from $1.90 to $1.98. For the next financial year, analysts forecast that the firm will post earnings of $2.21 per share, with EPS estimates ranging from $2.18 to $2.26. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that cover Entegris.

Entegris (NASDAQ:ENTG) last announced its earnings results on Thursday, July 26th. The semiconductor company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.04. Entegris had a return on equity of 24.90% and a net margin of 8.61%. The company had revenue of $383.06 million for the quarter, compared to the consensus estimate of $378.52 million. During the same period last year, the business posted $0.34 EPS. The company’s revenue was up 16.4% on a year-over-year basis.

ENTG has been the topic of several analyst reports. Loop Capital set a $46.00 target price on Entegris and gave the company a “buy” rating in a research note on Saturday, July 28th. BidaskClub downgraded Entegris from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 20th. Zacks Investment Research upgraded Entegris from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a research note on Tuesday, June 12th. Craig Hallum reiterated a “buy” rating on shares of Entegris in a research note on Friday, June 8th. Finally, Needham & Company LLC lifted their target price on Entegris from $42.00 to $44.00 and gave the company a “buy” rating in a research note on Friday, June 8th. Three analysts have rated the stock with a sell rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $42.00.

Shares of ENTG stock traded up $0.25 during midday trading on Friday, hitting $28.95. The company had a trading volume of 1,285,200 shares, compared to its average volume of 1,004,371. Entegris has a 52-week low of $28.20 and a 52-week high of $39.55. The company has a market capitalization of $4.10 billion, a P/E ratio of 20.24 and a beta of 1.40. The company has a current ratio of 3.79, a quick ratio of 2.49 and a debt-to-equity ratio of 0.62.

In related news, Director James Gentilcore sold 14,868 shares of Entegris stock in a transaction that occurred on Friday, August 31st. The stock was sold at an average price of $33.92, for a total value of $504,322.56. Following the sale, the director now directly owns 4,090 shares in the company, valued at $138,732.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Stuart Tison sold 8,630 shares of Entegris stock in a transaction that occurred on Tuesday, August 7th. The shares were sold at an average price of $36.01, for a total value of $310,766.30. Following the completion of the sale, the senior vice president now owns 78,402 shares in the company, valued at $2,823,256.02. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 36,024 shares of company stock worth $1,268,095. Company insiders own 1.20% of the company’s stock.

Several institutional investors have recently bought and sold shares of ENTG. Janus Henderson Group PLC purchased a new stake in shares of Entegris in the second quarter valued at approximately $55,149,000. Lord Abbett & CO. LLC purchased a new stake in shares of Entegris in the first quarter valued at approximately $55,461,000. JPMorgan Chase & Co. boosted its stake in shares of Entegris by 261.8% in the first quarter. JPMorgan Chase & Co. now owns 1,300,973 shares of the semiconductor company’s stock valued at $45,273,000 after buying an additional 941,403 shares in the last quarter. Voya Investment Management LLC raised its holdings in Entegris by 64.2% during the second quarter. Voya Investment Management LLC now owns 1,991,716 shares of the semiconductor company’s stock worth $67,519,000 after purchasing an additional 779,064 shares during the last quarter. Finally, Ardevora Asset Management LLP raised its holdings in Entegris by 458.5% during the second quarter. Ardevora Asset Management LLP now owns 906,488 shares of the semiconductor company’s stock worth $30,730,000 after purchasing an additional 744,188 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Entegris Company Profile

Entegris, Inc develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions for manufacturing processes in the semiconductor and other high-technology industries worldwide. It operates through three segments: Specialty Chemicals and Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH).

Read More: Do You Need a Fiduciary?

Get a free copy of the Zacks research report on Entegris (ENTG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Entegris (NASDAQ:ENTG)

Receive News & Ratings for Entegris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entegris and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.